PTEN and rheumatoid arthritis: Here, we report that tocilizumab and MIR31HG inhibit the activation of the AKT pathway in RA-FLS, and that this effect is mediated, at least in part, via the MIR31HG-miR-214-PTEN ceRNA regulatory network.